Drug regulation

You have access
The adverse effects of brand-name drug prescribing
Ken Flegel

CMAJ March 20, 2012 184 (5) 616; DOI: https://doi.org/10.1503/cmaj.112160
You have access
Pfizer advertises smoking cessation drug despite health warnings
Laura Eggertson

CMAJ February 07, 2012 184 (2) E127-E128; DOI: https://doi.org/10.1503/cmaj.109-4087
You have access
Unlocking Health Canada’s cache of trade secrets: mandatory disclosure of clinical trial results
Matthew Herder

CMAJ February 07, 2012 184 (2) 194-199; DOI: https://doi.org/10.1503/cmaj.110721
You have access
Analysis of drug coverage before and after the implementation of Canada’s Common Drug Review
John-Michael Gamble, Daniala L. Weir, Jeffrey A. Johnson and Dean T. Eurich

CMAJ November 22, 2011 183 (17) E1259-E1266; DOI: https://doi.org/10.1503/cmaj.110670
You have access
Books: The underbelly of the pharmaceutical industrial complex
Alan Cassels

CMAJ October 18, 2011 183 (15) E1155; DOI: https://doi.org/10.1503/cmaj.110096
You have access
CMA urges prescription-only antibiotics for agricultural use
Lauren Vogel

CMAJ September 20, 2011 183 (13) E1007-E1008; DOI: https://doi.org/10.1503/cmaj.109-3989
You have access
Can Health Canada protect Canadians from unsafe drugs?
Paul C. Hébert, Matthew B. Stanbrook, Noni MacDonald, Ken Flegel, Jane Coutts and Stuart MacLeod

CMAJ July 12, 2011 183 (10) 1125-1126; DOI: https://doi.org/10.1503/cmaj.110489
You have access
The brave new world of medicine by testimonial
Alan Cassels

CMAJ April 05, 2011 183 (6) 728; DOI: https://doi.org/10.1503/cmaj.101889
You have access
Health Canada “passes the buck” on diabetes drug, researcher charges
Laura Eggertson

CMAJ February 08, 2011 183 (2) E75-E76; DOI: https://doi.org/10.1503/cmaj.109-3762
You have access
Germany moves to lower drug prices
Kai Kupferschmidt

CMAJ February 08, 2011 183 (2) E77-E78; DOI: https://doi.org/10.1503/cmaj.109-3759

Main menu

User menu

Search

Drug regulation

Pages

Content

Information for

About